The rising interest in GLP-1 agonists for metabolic conditions has sparked a question about delivery routes : skin-applied devices versus capsules. Traditionally , GLP-1 therapies were exclusively https://phoebedhch485974.ampedpages.com/glp-1-transdermal-delivery-systems-vs-tablets-is-best-for-you-67965141